Search research articles
Contact Us
Filters
Showing results (601-610 of 620) with videos related to
Page
of 62
Sort By:
Molecular Cancer Therapeutics
|
December 21, 2013
Characterization of LY2228820 dimesylate, a potent and selective inhibitor of p38 MAPK with antitumor activity
Robert M Campbell, Bryan D Anderson, Nathan A Brooks, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 18, 2004
Aminoimidazo[1,2-a]pyridines as a new structural class of cyclin-dependent kinase inhibitors. Part 1: Design, synthesis, and biological evaluation
Carlos Jaramillo, J Eugenio de Diego, Chafiq Hamdouchi, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 14, 2003
Aryl[a]pyrrolo[3,4-c]carbazoles as selective cyclin D1-CDK4 inhibitors
Concha Sanchez-Martinez, Chuan Shih, Margaret M Faul, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
May 20, 2026
Proton Beam Therapy for Cancer in Children and Adolescents: A Retrospective Canadian Paediatric Tumour Consortium Study
K S K Wong, S Patel, L Lafay-Cousin, et al.
Expert Review of Neurotherapeutics
|
January 15, 2014
We know how to prescribe natalizumab for multiple sclerosis, but do we know how to withdraw it?
Yara D Fragoso, Niedja M Arruda, Walter O Arruda, et al.
Pediatric Neurology
|
October 18, 2013
Neuromyelitis optica with onset in childhood and adolescence
Yara Dadalti Fragoso, Maria L B Ferreira, Enedina M L Oliveira, et al.
Frontiers in Veterinary Science
|
July 5, 2022
Complex Feline Disease Mapping Using a Dense Genotyping Array
Isabel Hernandez, Jessica J Hayward, Jeff A Brockman, et al.
Science (New York, N.Y.)
|
April 30, 2011
The 2010 Mw 8.8 Maule megathrust earthquake of Central Chile, monitored by GPS
C Vigny, A Socquet, S Peyrat, et al.
Journal of Medicinal Chemistry
|
October 27, 2017
Discovery of N-(6-Fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128), a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) Inhibitor Effective at Tumor Suppression in a Cancer Xenograft Model
Kevin R Fales, F George Njoroge, Harold B Brooks, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 26, 2003
Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazoles
Thomas A Engler, Kelly Furness, Sushant Malhotra, et al.
Page
of 62
Search research articles
Search
Showing results (601-610 of 620) with videos related to
Sort By:
Page
of 62
Molecular Cancer Therapeutics
|
December 21, 2013
Characterization of LY2228820 dimesylate, a potent and selective inhibitor of p38 MAPK with antitumor activity
Robert M Campbell, Bryan D Anderson, Nathan A Brooks, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 18, 2004
Aminoimidazo[1,2-a]pyridines as a new structural class of cyclin-dependent kinase inhibitors. Part 1: Design, synthesis, and biological evaluation
Carlos Jaramillo, J Eugenio de Diego, Chafiq Hamdouchi, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 14, 2003
Aryl[a]pyrrolo[3,4-c]carbazoles as selective cyclin D1-CDK4 inhibitors
Concha Sanchez-Martinez, Chuan Shih, Margaret M Faul, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
May 20, 2026
Proton Beam Therapy for Cancer in Children and Adolescents: A Retrospective Canadian Paediatric Tumour Consortium Study
K S K Wong, S Patel, L Lafay-Cousin, et al.
Expert Review of Neurotherapeutics
|
January 15, 2014
We know how to prescribe natalizumab for multiple sclerosis, but do we know how to withdraw it?
Yara D Fragoso, Niedja M Arruda, Walter O Arruda, et al.
Pediatric Neurology
|
October 18, 2013
Neuromyelitis optica with onset in childhood and adolescence
Yara Dadalti Fragoso, Maria L B Ferreira, Enedina M L Oliveira, et al.
Frontiers in Veterinary Science
|
July 5, 2022
Complex Feline Disease Mapping Using a Dense Genotyping Array
Isabel Hernandez, Jessica J Hayward, Jeff A Brockman, et al.
Science (New York, N.Y.)
|
April 30, 2011
The 2010 Mw 8.8 Maule megathrust earthquake of Central Chile, monitored by GPS
C Vigny, A Socquet, S Peyrat, et al.
Journal of Medicinal Chemistry
|
October 27, 2017
Discovery of N-(6-Fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128), a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) Inhibitor Effective at Tumor Suppression in a Cancer Xenograft Model
Kevin R Fales, F George Njoroge, Harold B Brooks, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 26, 2003
Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazoles
Thomas A Engler, Kelly Furness, Sushant Malhotra, et al.
Page
of 62